Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

January 14, 2021January 14, 2021

Disease Activity in Black Children with pJIA Higher Than in Whites, Study Shows

News

Use of a treat-to-target approach, combined with a tool to support clinical decisions, significantly lowered disease activity in children with polyarticular juvenile idiopathic arthritis (pJIA) regardless of race and disease duration, ... Read more

November 19, 2020November 19, 2020

Methotrexate Prefilled Syringe, RediTrex, Now Available in US for pJIA, Other Disorders

News

Cumberland Pharmaceuticals has announced the launch of RediTrex, a new line of methotrexate prefilled syringes for the treatment of polyarticular juvenile idiopathic arthritis (pJIA), active rheumatoid arthritis, and severe psoriasis in the U.S. ... Read more

July 24, 2020July 24, 2020

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

News

Biological therapies or biologics may be more beneficial for young people with systemic juvenile idiopathic arthritis (sJIA) than for those with non-systemic disease, according to a review study. The work ... Read more

March 13, 2020March 13, 2020

Study: Adding RoActemra to Methotrexate Not Generally Effective in Lessening Uveitis in JIA Patients

News

Adding RoActemra (tocilizumab) to methotrexate failed to show effectiveness in children and adolescents with treatment-resistant uveitis — inflammation of the eye — associated with juvenile idiopathic arthritis (JIA), a Phase 2 ... Read more

February 11, 2020February 11, 2020

JIA and Rheumatoid Arthritis Share Several Genetic Traits, Study Shows

News

Juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA) share several genetic traits, most of which are associated with the immune system, a study shows. The data may help identify people at ... Read more

January 28, 2020January 28, 2020

JIA Children Have Lower Levels of Enzymes that Suppress Gene Activity, Study Suggests

News

Children with juvenile idiopathic arthritis (JIA), particularly boys, have significantly lower levels of DNA methyltransferases (DNMTs) — specific enzymes that suppress gene activity without changing their sequence — than healthy children, ... Read more

January 7, 2020January 7, 2020

Early DMARD Treatment Improves Quality of Life for Children with Polyarticular JIA, Study Suggests

News

Early aggressive treatment with biologic and synthetic disease-modifying anti-rheumatic drugs (DMARDs) improved the quality of life of children with polyarticular juvenile idiopathic arthritis (pJIA) in Finland, according to one-year data from ... Read more

December 13, 2019December 13, 2019

RNA Biomarkers in Synovial Fluid Can Accurately Identify JIA, Study Suggests

News

Researchers have identified three diagnostic biomarkers of juvenile idiopathic arthritis (JIA) in synovial fluid — the liquid between certain joints — which may help to distinguish the condition from septic ... Read more

December 10, 2019December 14, 2019

Cases of Severe Pneumonia in Finnish Children With JIA Have Decreased Over Time, Study Shows

News

Despite a higher overall frequency of pneumonia and greater use of immunosuppressive therapies, the occurrence of serious pneumonias has decreased in Finnish children with juvenile idiopathic arthritis (JIA) over time, a ... Read more

October 29, 2019October 29, 2019

Children with Polyarticular JIA Experience Worse Disability and Quality of Life, Swedish Study Reports

News

Children with polyarticular juvenile idiopathic arthritis (pJIA) — the second most common form of JIA — have worse functional disability and poorer quality of life, a Swedish study finds. While ... Read more